HopeStage
Back to all studies
CompletedNCT03373253

Treatment Patterns and Outcomes in Treatment-Resistant Depression Across Europe

About this titleRead the official source — NCT03373253
Observational studyAges 18–74Multiple countries
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 74 years.

Listed locations
Bilzen and 97 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: February 13, 2018
Recruitment status
Completed
Enrollment listed in the registry
830
Sponsor
Janssen-Cilag Ltd.
Sponsor type
Other organization
Study type
Observational
Intervention type
Interview / survey / observational
Locations
United Kingdom, Belgium, Germany, ...
Age range
From 18 Years to 74 Years
Official registry ID
NCT03373253
Official title
Show the full official title

Treatment-Resistant Depression Cohort in Europe

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bilzen, Belgium · Bruges, Belgium · Brussels, Belgium

80 more locations
  • Ghent, Belgium
  • Liège, Belgium
  • Ottignies, Belgium
  • Tielt, Belgium
  • Bamberg, Germany
  • Berlin, Germany
  • Chemnitz, Germany
  • Dresden, Germany
  • Essen, Germany
  • Frankfurt, Germany
  • Gelsenkirchen, Germany
  • Hamburg, Germany
  • Liebenburg, Germany
  • Magdeburg, Germany
  • Mainz, Germany
  • Mittweida, Germany
  • München, Germany
  • Oberhausen, Germany
  • Oranienburg, Germany
  • Pfaffenhofen, Germany
  • Schwerin, Germany
  • Siegen, Germany
  • Stralsund, Germany
  • Bari, Italy
  • Bergamo, Italy
  • Brescia, Italy
  • Catania, Italy
  • Catanzaro, Italy
  • Genova, Italy
  • Genzano di Roma, Italy
  • Lecce, Italy
  • Messina, Italy
  • Milan, Italy
  • Monza, Italy
  • Novara, Italy
  • Parma, Italy
  • Pisa, Italy
  • Roma, Italy
  • Rome, Italy
  • Siena, Italy
  • Torino, Italy
  • Torrette Di Ancona, Italy
  • Heerde, Netherlands
  • Helmond, Netherlands
  • Zeist, Netherlands
  • Aveiro, Portugal
  • Beja, Portugal
  • Braga, Portugal
  • Coimbra, Portugal
  • Evora, Portugal
  • Guilhufe - Penafiel, Portugal
  • Leiria, Portugal
  • Lisbon, Portugal
  • Porto, Portugal
  • Barcelona, Spain
  • Ciudad Real, Spain
  • Elche, Spain
  • Las Palmas de Gran Canaria, Spain
  • Madrid, Spain
  • Móstoles, Spain
  • Oviedo, Spain
  • Pontevedra, Spain
  • Sabadell, Spain
  • Torrevieja, Spain
  • Valencia, Spain
  • Zafra, Spain
  • Aberdeen, United Kingdom
  • Bristol, United Kingdom
  • Chertsey, United Kingdom
  • Darlington, United Kingdom
  • Derby, United Kingdom
  • Edinburgh, United Kingdom
  • Lichfield, United Kingdom
  • London, United Kingdom
  • Northampton, United Kingdom
  • Radlett, United Kingdom
  • Southampton, United Kingdom
  • Truro, United Kingdom
  • Weymouth, United Kingdom
  • Winsford, United Kingdom

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Janssen-Cilag Ltd.

Who was this study for?

Listed age limits: 18 years to 74 years.

Want to explore more studies?

Explore studies